2C-B was initially synthesized and tested for psychoactivity in 1974 with the American chemist and copyright researcher Alexander Shulgin, who was investigating novel copyright compounds depending on the chemical composition of mescaline. United Kingdom: 2C-B is a category A drug while in the United Kingdom as a result of the phenethylamine catc